ArticleHuman vaccines & immunotherapeutics2024

The 13-year long-term follow-up on the effectiveness and immunogenicity of the quadrivalent human papillomavirus vaccine in Chinese females vaccinated at 20-45 years of age.

Tianmeng Wen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.